30 March 2015 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer...
Read moreGlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare...
Read moreMultisorb Technologies has announced it will be exhibiting at Interphex in New York. The event will take place from 20-22...
Read moreUS-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a...
Read moreCipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel...
Read moreMerck KGaA is the latest company to join Big Pharma's recent round of executive musical chairs. The German drugmaker is...
Read more"There is no second thought on the capability of the Indian pharma industry and Bangalore is gearing up to play...
Read moreIn a strategic development, the zonal office of Central Drugs Standard Control Organisation (CDSCO) Ahmedabad was recognised with the certification...
Read moreAlthough essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the...
Read moreGlaxoSmithKline said on Thursday that its chairman-designate Philip Hampton would take charge of Britain's biggest drugmaker from May 7, an...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
